ClinConnect ClinConnect Logo
Search / Trial NCT07019493

Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke

Launched by THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH · Jun 5, 2025

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

Recovery Young Stroke Ischemic Stroke Hemorrhagic Stroke Poststroke Fatigue Post Stroke Cognitive Impairment Function Mood

ClinConnect Summary

The "Young Stroke Service Deep Phenotyping" trial is a research study taking place in several hospitals in Melbourne, Australia. It aims to learn more about young adults aged 18 to 55 who have experienced a stroke. The main focus is to see how effective and practical a detailed health assessment process—known as "deep phenotyping"—can be in understanding each participant's unique recovery journey. This involves gathering various health information and samples to explore how different factors, like age, sex, lifestyle, and biological markers, may affect recovery after a stroke.

To participate in this study, individuals must be between 18 and 55 years old and have had a confirmed stroke within the last month. Unfortunately, those with severe illnesses or major psychiatric conditions that require medical treatment cannot take part. Participants will go through a comprehensive assessment process, and the findings from this pilot study will help inform larger future studies aimed at improving recovery for young stroke survivors.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Between 18 and 55 years.
  • 2. Within one month of acute stroke confirmed with standard of care brain imaging or clinical diagnosis
  • Exclusion Criteria:
  • 1. Severe, intercurrent or progressive illness likely to EITHER
  • 1. Have a prognosis for survival under 24 months; OR
  • 2. In the opinion of the investigator will mask the importance to the individual participant data (e.g. severe MS, dementia, etc)
  • 2. Major psychiatric condition requiring medical intervention

About The Florey Institute Of Neuroscience And Mental Health

The Florey Institute of Neuroscience and Mental Health is a leading Australian research organization dedicated to advancing our understanding of the brain and mind through innovative scientific inquiry. With a focus on translating research findings into clinical applications, the Institute conducts rigorous clinical trials aimed at improving treatments for neurological and psychiatric disorders. Committed to excellence in research, the Florey Institute collaborates with national and international partners to foster breakthroughs in neuroscience, ultimately enhancing patient care and outcomes in mental health and neurological health fields.

Locations

Heidelberg, Victoria, Australia

Patients applied

0 patients applied

Trial Officials

Vincent Thijs, MD, PhD

Principal Investigator

Florey Institute of Neuroscience and Mental Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported